Patient info Search Menu

Amlodipine 10 mg tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
10 mg
Contains active substance:
ATC code:

Patient leaflet - Amlodipine 10 mg tablets

1. What Amlodipine is and what it is used for

Amlodipine contains the active substance amlodipine which belongs to a group of medicines called calcium antagonists.

Amlodipine is used to treat high blood pressure (hypertension) or a certain type of chest pain called angina, a rare form of which is Prinzmetal’s or variant angina.

In patients with high blood pressure this medicine works by relaxing blood vessels, so that blood passes through them more easily. In patients with angina Amlodipine works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. This medicine does not provide immediate relief of chest pain from angina.

2. What you need to know before you take Amlodipine

Do not take Amlodipine

  • If you are allergic (hypersensitive) to amlodipine, or any of the other ingredients of this medicine listed in section 6, or to any other calcium antagonists. This may be itching, reddening of the skin or difficulty in breathing.
  • If you have severe low blood pressure (hypotension).
  • If you have narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (a condition where your heart is unable to supply enough blood to the body).
  • If you suffer from heart failure after a heart attack.

Warnings and precautions

Talk to your doctor or pharmacist before taking Amlodipine.

You should inform your doctor if you have or have had any of the following conditions:

  • Recent heart attack
  • Heart failure
  • Severe increase in blood pressure (Hypertensive crisis)
  • Liver disease
  • You are elderly and your dose needs to be increased

Children and adolescents

Amlodipine has not been studied in children under the age of 6 years. Amlodipine should only be used for hypertension in children and adolescents from 6 years to 17 years of age (see section 3). For more information, talk to your doctor.

Other medicines and Amlodipine

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Amlodipine may affect or be affected by other medicines, such as:

  • ketoconazole, itraconazole (anti-fungal medicines)
  • ritonavir, indinavir, nelfinavir (so called protease inhibitors used to treat HIV)
  • rifampicin, erythromycin, clarithromycin (antibiotics)
  • hypericum perforatum (St. John’s Wort)
  • verapamil, diltiazem (heart medicines)
  • dantrolene (infusion for severe body temperature abnormalities)
  • tacrolimus, sirolimus, temsirolimus, and everolimus (medicines used to alter the way your immune system works)
  • simvastatin (cholesterol lowering medicine)
  • cyclosporine (an immunosuppressant)

Amlodipine may lower your blood pressure even more if you are already taking other medicines to treat your high blood pressure.

Amlodipine with food and drink

Grapefruit juice and grapefruit should not be consumed by people who are taking Amlodipine. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Amlodipine.

Pregnancy and breast-feeding

Pregnancy

The safety of amlodipine in human pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take Amlodipine. Breast-feeding

Amlodipine has been shown to pass into breast milk in small amounts. If you are breast-feeding or about to start breast-feeding you must tell your doctor before taking Amlodipine. Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Amlodipine may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately. Amlodipine contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Amlodipine

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended initial dose is Amlodipine 5 mg once daily. The dose can be increased to Amlodipine 10 mg once daily.

This medicine can be used before or after food and drinks. You should take this medicine at the same time each day with a drink of water. Do not take Amlodipine with grapefruit juice. Amlodipine 5mg tablets can be divided into equal doses of 2.5mg.

Use in children and adolescents

For children and adolescents (6-17 years old), the recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. Amlodipine 5 mg tablets can be divided into halves to provide a 2.5 mg dose.

It is important to keep taking the tablets. Do not wait until your tablets are finished before seeing your doctor.

If you take more Amlodipine than you should

Taking too many tablets may cause your blood pressure to become low or even dangerously low. You may feel dizzy, lightheaded, faint or weak. If blood pressure drop is severe enough shock can occur. Your skin could feel cool and clammy and you could lose consciousness. Seek immediate medical attention if you take too many Amlodipine tablets.

Excess fluid may accumulate in your lungs (pulmonary oedema) causing shortness of breath that may develop up to 24-48 hours after intake.

If you forget to take Amlodipine

Do not worry. If you forget to take a tablet, leave out that dose completely. Take your next dose at the right time. Do not take a double dose to make up for a forgotten dose.

Package leaflet: Information for the user Amlodipine 5 mg and 10 mg tablets

Amlodipine

Back

XX XXX XXXX XX If you stop taking Amlodipine

Your doctor will advise you how long to take this medicine. Your condition may return if you stop using this medicine before you are advised.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following side effects after taking this medicine.

  • Sudden wheeziness, chest pain, shortness of breath or difficulty in breathing
  • Swelling of eyelids, face orlips
  • Swelling of the tongue and throat which causes great difficulty breathing
  • Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome, toxic epidermal necrolysis) or other allergi creactions
  • Heart attack, abnormal heartbeat
  • Inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell

The following very common side effect has been reported. If this causes you problems or if it lasts for more than one week, you should contact your doctor.

Very common: may affect more than 1 in 10 people

  • Oedema (fluidretention)

The following common side effects have been reported. If any of these cause you problems or if they last for more than one week, you should contact your doctor.

Common: may affect up to 1 in 10 people

  • Headache, dizziness, sleepiness (especially at the beginning of treatment)
  • Palpitations (awareness of your heart beat), flushing
  • Abdominal pain, feeling sick (nausea)
  • Altered bowel habits, diarrhoea, constipation, indigestion
  • Tiredness, weakness
  • Visual disturbances, double vision
  • Muscle cramps
  • Ankle swelling

Other side effects that have been reported include the following list. If any of these get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Uncommon: may affect up to 1 in 100 people

  • Mood changes, anxiety, depression, sleeplessness
  • Trembling, taste abnormalities, fainting
  • Numbness or tingling sensation in your limbs, loss of pain sensation
  • Ringing in the ears
  • Low blood pressure
  • Sneezing/running nose caused by inflammation of the lining of the nose (rhinitis)
  • Cough
  • Dry mouth, vomiting (being sick)
  • Hair loss, increased sweating, itchy skin, red patches on skin, skin discolouration
  • Disorder in passing urine, increased need to urinate at night, increased number of times of passing urine
  • In ability to obtain an erection, discomfort or enlargement of the breasts in men
  • Pain, feeling unwell
  • Joint or muscle pain, backpain
  • Weight increase or decrease

Rare: may affect up to 1 in 1,000 people

  • Confusion

Very rare: may affect up to 1 in 10,000 people

  • Decreased numbers of white blood cells, decrease in blood platelets which may result in unusual bruising or easy bleeding
  • Excess sugar in blood (hyperglycaemia)
  • A disorder of the nerves which can cause muscular weakness, tingling or numbness
  • Swelling of the gums, bleeding gums
  • Abdominal bloating (gastritis)
  • Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), liver enzyme increase which may have an effect on some medical tests
  • Increased muscle tension
  • Inflammation of blood vessels, often with skin rash
  • Sensitivity to light
  • Disorders combining rigidity, tremor, and/or movement disorders

Not known: frequency cannot be estimated from the available data

  • Trembling, rigid posture, mask-like face, slow movements and a shuffling, unbalanced walk Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store’. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Amlodipine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the pack after ‘EXP’. The expiry date refers to the last day of that month.

This medicinal product does not require any special temperature storage conditions. Store in the original package to protect from light.

Do not throw away any medicines via waste water or house hold waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Amlodipine contains

The active substance in Amlodipine 5 mg tablets is amlodipine (as besilate). The active substance in Amlodipine 10 mg tablets is amlodipine (as besilate). The other ingredients are calcium hydrogen phosphate anhydrous, magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica and sodium starch glycolate type A.

What Amlodipine looks like and contents of the pack

5 mg tablets: White to off white, emerald shaped tablets debossed with “J” on one side of break line and “5” on other side of break line on one side, plain on other side.

The tablet can be divided into equal doses.

10 mg tablets: White to off white, emerald shaped tablets debossed with “J10” on one side and plain on other side.

Amlodipine 5 mg tablets are available in blisters containing 4, 10, 14, 20, 28, 30, 50, 60, 98, 100, 300, 500 tablets.

Amlodipine 10 mg tablets are available in blisters containing 4, 10, 14, 20, 28, 30, 50, 60, 98, 100, 300, 500 tablets.

Not all pack sizes may be marketed.

POM

Manufacturer:

Rudipharm Limited

Oak House, Reeds Crescent, Watford, WD24 4QP, UK Marketing Authorisation Holder:

Rudipharm Limited

Unit 6, Salbrook Road Industrial Estate

Salbrook Road, Redhill, Surrey, RH1 5GJ, UK

To listen to or request a copy of this leaflet in Braille, large print or audio please call, 1293827819(UK only)

Please be ready to give the following information:

Product name Reference number

Amlodipine 5mg Tablets PL 49565/0119

Amlodipine10mg Tablets PL 49565/0120

This leaflet was last revised in May 2026.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49565/0120

Last revision stated in the text: May 2026 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Amlodipine 10 mg tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Amlodipine
Strength? 10 mg
Pharmaceutical form? Oral tablet
White or almost white, flat, bevelled edges, round [diameter 10 mm] tablet debossed with "C" on one side and "59" on the other side.
How is it taken? Oral
Excipients? Microcrystalline cellulose [E 460a], Calcium hydrogen phosphate, Sodium starch glycolate, Magnesium stearate [E 470B]
Pack sizes 28 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC)? Calcium channel blockers, selective calcium channel blockers with mainly vascular effects
  1. C Cardiovascular system drugs
    1. C08 Calcium channel blockers
      1. C08C Selective calcium channel blockers with mainly vascular effects
        1. C08CA Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects
          1. C08CA01 amlodipine
Marketing authorisation? PL 16363/0250 (first authorised 28 January 2025), PL 49565/0120
Marketing authorisation holder? Milpharm Limited
Codes? GTIN 5060705240847, 8901175007486 · BNF 02060200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.0.0 of 2 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.